13F

Stock

Enliven Therapeutics, Inc.

ELVN · held by 4 managers

Reported value

$7.55M

Holders

4

+0 new · −0 exited

Holders’ est. mark

$29K

Price effect on 1 books still in the name

Largest holder

$5.29M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY258.4K$5.29MHeld
BARCLAYS PLC70.7K$1.45M$29KCut−$13K
BANK OF AMERICA CORP /DE/23.5K$481.9KHeld
TUDOR INVESTMENT CORP ET AL16.3K$333.7KHeld

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.